FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W830383850> ?p ?o ?g. }

• W830383850 abstract "It is now understood that CD4+ T cells play a central role in antitumour immunity; they are important in the priming of CTL and can augment cytotoxicity; they are also responsible for enhancing antitumour responses via indirect mechanisms such as recruitment of accessory cells to the tumour site and they are crucial in the formation of memory T cells. CD4+ T cells recognise antigen in the context of peptide presented on MHC class II molecules, therefore recent research has focused on the identification of these peptides in order to formulate more effective immunotherapeutic strategies. As such, the aim of this study was to identify novel MHC class II HLA-DR1 and HLA-DR4 restricted immunogenic peptides derived from the MART-1 and Tyrosinase tumour antigens. A computer algorithm (SYFPEITHI; available on the World Wide Web) was used to predict immunogenic peptides from the two tumour antigens; these peptides were then used to immunise HLA-DR1 and HLA-DR4 transgenic mice in order to assess their immunogenicity. At the same time efforts were made to optimise the screening process by fully characterising the BM-DC used in proliferation assays and employing antioxidants in conjunction with T cell culture. A second aspect of the project utilised p53 peptides in order to investigate the effects of protein specific T cell help on the generation of effector and memory CTL. Efforts were made to maximise the efficiency of the MHC class II peptide screening method by optimising expression of co-stimulatory molecules and cytokine production by BM-DC. Testing of BM-DC derived from FVB/N-DR1, C57bl/6-DR4 and C57bl/6 HHD II HLA-A2 transgenic mice revealed that differing maturation protocols were required to generate BM-DC with the optimal T cell stimulatory capacity, depending upon the strain of transgenic mice employed. The screening process was further optimised by the use of Vitamin E in conjunction with T cell culture; this antioxidant was found to increase peptide specific proliferative responses against the immunised peptide. Using the optimised screening protocols, immunisation of transgenic mice with predicted epitopes led to the discovery of the novel HLA-DR1 restricted MART-129-43 and the HLA-DR1/DR4 restricted Tyrosinase147-161 peptides. Further experiments also indicated that the Tyrosinase protein was processed by murine dendritic cells to produce the Tyrosinase147-161 peptide. This study demonstrated that HLA-DR restricted responses to novel peptide can be obtained in HLA-DR1 and HLA-DR4 transgenic mice. In order to determine the most effective type of T cell help (protein specific/nonspecific) for augmentation of a CTL response a number of experiments were performed using p53 class I peptides in conjunction with either a Hep B or p53 class II helper peptide. Results showed that in short term, in vitro, experiments the p53 helper peptide augmented cytotoxicity more than a Hep B helper peptide; however in long term experiments involving recall by memory CTL, the Hep B helper peptide out-performed the p53 epitope; further investigation is required into these phenomena. Collectively these data demonstrate that the use of transgenic mice allows for rapid screening of novel MHC class II peptide epitopes that could be useful in the formulation of future cancer vaccines. It also highlights the requirement for further investigation into the precise nature of the T cell help required to maximise antitumour effects and thegeneration of memory CTL." @default.
• W830383850 created "2016-06-24" @default.
• W830383850 creator A5034600456 @default.
• W830383850 date "2006-01-01" @default.
• W830383850 modified "2023-09-23" @default.
• W830383850 title "Identification of candidate tumour antigen peptides with immunogenic potential for use in cancer immunotherapy." @default.
• W830383850 hasPublicationYear "2006" @default.
• W830383850 type Work @default.
• W830383850 sameAs 830383850 @default.
• W830383850 citedByCount "0" @default.
• W830383850 crossrefType "dissertation" @default.
• W830383850 hasAuthorship W830383850A5034600456 @default.
• W830383850 hasConcept C100701293 @default.
• W830383850 hasConcept C147483822 @default.
• W830383850 hasConcept C147969180 @default.
• W830383850 hasConcept C151730666 @default.
• W830383850 hasConcept C154317977 @default.
• W830383850 hasConcept C167672396 @default.
• W830383850 hasConcept C170627219 @default.
• W830383850 hasConcept C188280979 @default.
• W830383850 hasConcept C202751555 @default.
• W830383850 hasConcept C203014093 @default.
• W830383850 hasConcept C207936829 @default.
• W830383850 hasConcept C2776090121 @default.
• W830383850 hasConcept C2777701055 @default.
• W830383850 hasConcept C2779343474 @default.
• W830383850 hasConcept C2780674031 @default.
• W830383850 hasConcept C2780868878 @default.
• W830383850 hasConcept C502942594 @default.
• W830383850 hasConcept C55493867 @default.
• W830383850 hasConcept C59822182 @default.
• W830383850 hasConcept C81444415 @default.
• W830383850 hasConcept C86803240 @default.
• W830383850 hasConcept C8891405 @default.
• W830383850 hasConceptScore W830383850C100701293 @default.
• W830383850 hasConceptScore W830383850C147483822 @default.
• W830383850 hasConceptScore W830383850C147969180 @default.
• W830383850 hasConceptScore W830383850C151730666 @default.
• W830383850 hasConceptScore W830383850C154317977 @default.
• W830383850 hasConceptScore W830383850C167672396 @default.
• W830383850 hasConceptScore W830383850C170627219 @default.
• W830383850 hasConceptScore W830383850C188280979 @default.
• W830383850 hasConceptScore W830383850C202751555 @default.
• W830383850 hasConceptScore W830383850C203014093 @default.
• W830383850 hasConceptScore W830383850C207936829 @default.
• W830383850 hasConceptScore W830383850C2776090121 @default.
• W830383850 hasConceptScore W830383850C2777701055 @default.
• W830383850 hasConceptScore W830383850C2779343474 @default.
• W830383850 hasConceptScore W830383850C2780674031 @default.
• W830383850 hasConceptScore W830383850C2780868878 @default.
• W830383850 hasConceptScore W830383850C502942594 @default.
• W830383850 hasConceptScore W830383850C55493867 @default.
• W830383850 hasConceptScore W830383850C59822182 @default.
• W830383850 hasConceptScore W830383850C81444415 @default.
• W830383850 hasConceptScore W830383850C86803240 @default.
• W830383850 hasConceptScore W830383850C8891405 @default.
• W830383850 hasLocation W8303838501 @default.
• W830383850 hasOpenAccess W830383850 @default.
• W830383850 hasPrimaryLocation W8303838501 @default.
• W830383850 hasRelatedWork W1572593852 @default.
• W830383850 hasRelatedWork W1997786424 @default.
• W830383850 hasRelatedWork W2038917355 @default.
• W830383850 hasRelatedWork W2062817493 @default.
• W830383850 hasRelatedWork W2068019405 @default.
• W830383850 hasRelatedWork W2420652605 @default.
• W830383850 hasRelatedWork W2559930465 @default.
• W830383850 hasRelatedWork W2621418439 @default.
• W830383850 hasRelatedWork W2621900003 @default.
• W830383850 hasRelatedWork W2730553820 @default.
• W830383850 hasRelatedWork W2790473823 @default.
• W830383850 hasRelatedWork W2792905243 @default.
• W830383850 hasRelatedWork W2810903938 @default.
• W830383850 hasRelatedWork W2910081451 @default.
• W830383850 hasRelatedWork W3091981329 @default.
• W830383850 hasRelatedWork W3104041147 @default.
• W830383850 hasRelatedWork W52636544 @default.
• W830383850 hasRelatedWork W2815282456 @default.
• W830383850 hasRelatedWork W2820152782 @default.
• W830383850 hasRelatedWork W2877175713 @default.
• W830383850 isParatext "false" @default.
• W830383850 isRetracted "false" @default.
• W830383850 magId "830383850" @default.
• W830383850 workType "dissertation" @default.